FATE - Fate Therapeutics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts7477
Avg. Estimate-0.25-0.08-0.97-0.56
Low Estimate-0.27-0.27-1-1.07
High Estimate-0.210.39-0.921.67
Year Ago EPS-0.21-0.24-1.05-0.97
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts7477
Avg. Estimate940k1.03M4.03M4.95M
Low Estimate500k1M3.6M2.05M
High Estimate1.03M1.1M4.11M12.2M
Year Ago Sales1.03M1.03M4.4M4.03M
Sales Growth (year/est)-8.50%0.30%-8.50%22.80%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.29-0.2-0.24-0.24
EPS Actual-0.21-0.24-0.23-0.26
Difference0.08-0.040.01-0.02
Surprise %27.60%-20.00%4.20%-8.30%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.25-0.08-0.97-0.56
7 Days Ago-0.25-0.23-0.97-0.91
30 Days Ago-0.26-0.23-0.98-0.94
60 Days Ago-0.26-0.23-0.98-0.96
90 Days Ago-0.25-0.22-0.97-0.94
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/A1N/A1
Up Last 30 Days1112
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesFATEIndustrySectorS&P 500
Current Qtr.-19.00%N/AN/A0.26
Next Qtr.66.70%N/AN/A0.34
Current Year7.60%N/AN/A0.09
Next Year42.30%N/AN/A0.15
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A